iShares Trust: iShares Nasdaq Biotechnology Index Fund (IBB) Share Price ($):124.79 Price Change: 1.29 (1.04%)

Exchange: U.S.: Nasdaq   Industry: Health/Biotech   

Last 10 Quotes:

What's This?
    Previous Close123.50
    Volume438,779
    Day's Range123.24 - 124.89
    52-Week Range83.96 - 126.90
    Year-to-Date Return18.24%
    1-Year Return15.85%
    3-Year Annualized Return23.81%
    5-Year Annualized Return8.89%
    Chart for IBB
    Find a Broker »

    Investment Info

    Expense Ratio0.48
    Net Assets$ 1,892 mil
    Alpha0.51
    R-Squared0.60
    Dividend (Yield)$0.03 (0.03%)
    Avg. Market Cap$ 16,005 mil
    Beta0.89
    Price/Earnings30.67
    Ex-Dividend Date3/23/2012
    Turnover13.00
    Standard Deviation5.06
    Price/Book7.87
    Management CompanyBlackRock Fund Advisors
    AdministratorBlackRock Fund Advisors

    Sector Weightings

    Top 10 Holdings

    Company of Name % of Total # of Shares Held
    1. Alexion Pharmaceuticals Inc ORD 7.63% 1,514,976
    2. Amgen Inc ORD 7.16% 1,940,544
    3. Regeneron Pharmaceuticals Inc ORD 6.67% 1,054,656
    4. Celgene Corp ORD 6.28% 1,494,598
    5. Gilead Sciences Inc ORD 5.43% 2,048,646
    6. Biogen Idec Inc ORD 4.91% 718,145
    7. Teva Pharmaceutical Industries Ltd DR 4.61% 1,884,960
    8. Perrigo Co ORD 3.99% 712,833
    9. Vertex Pharmaceuticals Inc ORD 3.49% 1,569,398
    10. Mylan Inc ORD 2.97% 2,334,378
    % of Total Holdings 53.14%  

    Stories & Blogs: Around the Web

    5/14/2012   NASDAQ Changes Up Biotech Index Members & Weightings (24/7 Wall St)

    View Snapshot for: 

    tools

    Stock Screener

    Portfolio Tracker

    See More Tools
    From the Magazine
    Read More Read More Read More Read More

    Also